Shanghai, China

Aili Kang

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aili Kang: Innovator in Cardiac Arrhythmia Treatment

Introduction

Aili Kang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating cardiac arrhythmia. His innovative work has led to the filing of a patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Aili Kang holds a patent for N-substituted benzyl or phenyl aromatic sulfamides compounds. This patent, titled "N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)benzyl aromatic sulfonamides and N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)phenyl aromatic sulfonamides," describes the use of these compounds in the prevention and treatment of cardiac arrhythmia. The compounds are synthesized through a series of chemical reactions, including the condensation of aromatic sulfochlorides with p-hydroxybenzylamine or p-aminophenol, followed by a Mannich reaction. The resulting diamines are then reacted with various acids to form their respective salts. Aili Kang's patent represents a significant advancement in therapeutic options for patients suffering from this condition.

Career Highlights

Aili Kang is affiliated with the Chinese Academy of Sciences, where he conducts research and development in the field of medicinal chemistry. His work has not only contributed to the scientific community but has also paved the way for potential new treatments for cardiac arrhythmia. With a focus on innovative solutions, Aili continues to push the boundaries of what is possible in medical science.

Collaborations

Aili Kang collaborates with esteemed colleagues, including Weizhou Chen and Yunxin Bu. These partnerships enhance the research efforts and contribute to the successful development of new therapeutic compounds.

Conclusion

Aili Kang's contributions to the field of medicinal chemistry, particularly in the treatment of cardiac arrhythmia, highlight his innovative spirit and dedication to improving patient outcomes. His patent and ongoing research efforts are a testament to the impact that dedicated inventors can have on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…